These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9871899
1. [Severity of respiratory syncytial virus infection influenced by clinical risk factors and subtype A and B in hospitalized children]. Bergsträsser E, Zbinden R, Minder C, Gnehm HE. Klin Padiatr; 1998; 210(6):418-21. PubMed ID: 9871899 [Abstract] [Full Text] [Related]
5. Impact of respiratory syncytial virus infection as a cause of lower respiratory tract infection in children younger than 3 years of age in Japan. Kaneko M, Watanabe J, Kuwahara M, Ueno E, Hida M, Kinoshita A, Sone T. J Infect; 2002 May; 44(4):240-3. PubMed ID: 12099731 [Abstract] [Full Text] [Related]
6. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity. Lanari M, Giovannini M, Giuffré L, Marini A, Rondini G, Rossi GA, Merolla R, Zuccotti GV, Salvioli GP, Investigators R.A.DA.R. Study Group. Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280 [Abstract] [Full Text] [Related]
7. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173 [Abstract] [Full Text] [Related]
12. [Relationship between respiratory syncytial virus subtype and clinical severity in bronchiolitis]. Neves Barreira J, Fonseca C, Cardoso M, Azevedo A, Bonito Vítor A. An Esp Pediatr; 2001 Jun; 54(6):559-66. PubMed ID: 11412403 [Abstract] [Full Text] [Related]
14. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Wilkesmann A, Ammann RA, Schildgen O, Eis-Hübinger AM, Müller A, Seidenberg J, Stephan V, Rieger C, Herting E, Wygold T, Hornschuh F, Groothuis JR, Simon A, DSM RSV Ped Study Group. Pediatr Infect Dis J; 2007 Jun; 26(6):485-91. PubMed ID: 17529864 [Abstract] [Full Text] [Related]
15. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443 [Abstract] [Full Text] [Related]
18. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E, IRIS Study Group. Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927 [Abstract] [Full Text] [Related]
20. [Low incidence of nosocomial respiratory syncytial virus infections among children younger than 12 months in the Department of Pediatrics, Sophia Children's Hospital at Rotterdam]. Kneyber MC, de Groot R, Moll HA. Ned Tijdschr Geneeskd; 2000 Jan 01; 144(1):24-7. PubMed ID: 10665300 [Abstract] [Full Text] [Related] Page: [Next] [New Search]